Compare NUAI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUAI | STXS |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | NUAI | STXS |
|---|---|---|
| Price | $2.79 | $2.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 6.0M | 418.7K |
| Earning Date | 02-14-2026 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $843,029.00 | ★ $30,075,000.00 |
| Revenue This Year | N/A | $24.21 |
| Revenue Next Year | N/A | $29.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.89 | 19.62 |
| 52 Week Low | $0.32 | $1.54 |
| 52 Week High | $7.87 | $3.59 |
| Indicator | NUAI | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 42.00 |
| Support Level | $2.88 | $2.39 |
| Resistance Level | $4.97 | $2.48 |
| Average True Range (ATR) | 0.58 | 0.09 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 5.20 | 10.91 |
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.